Active Monitoring Is Noninferior to Guideline Concordant Care in Low-Risk DCIS
Postoperative Radiation Therapy Improves HRQOL, Safety in Early-Stage HR+/HER2– Breast Cancer
Baseline ctDNA Is Associated With Larger Pathological Tumors in HR+ Early Breast Cancer
Elacestrant Improves Real-World Time to Next Treatment or Treatment Discontinuation in ESR1+ HR+/HER2– Breast Cancer
